Office Technology

Showing 1328 articles

Sanofi Halts mRNA Flu Vaccine Trial Amid Surging U.S. Influenza Season

French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.

Business

Microsoft's $357 Billion Plunge: A Buying Opportunity or a Warning Sign?

Microsoft shares suffered their worst single-day decline since 2020, erasing $357 billion in market value after quarterly results disappointed investors. While concerns over AI spending and Azure growth metrics fueled the sell-off, some analysts see a potential entry point for long-term investors as the tech giant addresses capacity constraints.